19th Nov 2010 10:10
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
UPDATE ON NOMAD AND BROKER POSITION
Porton Down, UK, 19 November 2010: GW Pharmaceuticals (AIM: GWP) hereby provides notification that, following the announcement by Piper Jaffray & Co. on 20 October 2010 that it is discontinuing its equities distribution operations in Europe, Piper Jaffray Ltd. has informed GW that it is no longer able to act as a broker to AIM listed companies in the UK. Piper Jaffray Ltd. has therefore resigned as the Company's broker with immediate effect but will continue to act as the Company's NOMAD until an alternative NOMAD and broker is appointed.
The Company is in discussions with alternative advisers and intends to retain a new NOMAD and Broker before the end of the calendar year.
For further information, please contact:
GW Pharmaceuticals PLC Adam George, Company Secretary | +44 (0)1980 557 000 |
Piper Jaffray Ltd (Nominated Adviser) Neil Mackison/Rupert Winckler | +44 (0) 203 142 8700 |
Related Shares:
GWP.L